Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 


 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 1-11442

 


 

CHART INDUSTRIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 


 

Delaware   34-1712937

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

5885 Landerbrook Dr., Suite 205, Cleveland, Ohio 44124

(Address of Principal Executive Offices) (ZIP Code)

 

Registrant’s Telephone Number, Including Area Code: (440) 753-1490

 

Not Applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13, or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.    Yes  x    No  ¨

 

At September 30, 2004, there were 5,358,075 outstanding shares of the Company’s Common Stock, par value $.01 per share.

 

Page 1 of 30 sequentially numbered pages.

 



Table of Contents

CHART INDUSTRIES, INC.

 

INDEX

 

     Page

Part I. Financial Information     

Item 1: Financial Statements

    

Condensed Consolidated Balance Sheets as of September 30, 2004 and December 31, 2003

   3

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2004 and 2003

   4

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2004 and 2003

   5

Notes to Unaudited Condensed Consolidated Financial Statements

   6-17

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

   18-25

Item 3. Quantitative and Qualitative Disclosures About Market Risk

   26

Item 4: Controls and Procedures

   26
Part II. Other Information     

Item 1: Legal Proceedings

   27

Item 2: Unregistered Sales of Equity Securities

   28

Item 6: Exhibits and Reports on Form 8-K

   28

Signatures

   29

Exhibit Index

   30

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share amounts)

 

     September 30,
2004


   December 31,
2003


     (Unaudited)     

ASSETS

             

Current Assets

             

Cash and cash equivalents

   $ 17,692    $ 18,600

Accounts receivable, net

     42,071      39,806

Inventories, net

     42,178      34,788

Other current assets

     25,610      29,983

Assets held for sale

     7,742      550
    

  

Total Current Assets

     135,293      123,727

Property, plant and equipment, net

     38,230      45,762

Reorganization value in excess of amounts allocable to identifiable assets

     75,263      76,540

Identifiable intangible assets, net

     49,174      51,281

Other assets, net

     1,292      2,327
    

  

TOTAL ASSETS

   $ 299,252    $ 299,637
    

  

LIABILITIES AND SHAREHOLDERS’ EQUITY

             

Current Liabilities

             

Accounts payable

   $ 24,064    $ 22,297

Customer advances and billings in excess of contract revenue

     12,965      7,250

Accrued expenses and other current liabilities

     30,520      28,419

Current maturities of long-term debt

     3,360      3,480
    

  

Total Current Liabilities

     70,909      61,446

Long-term debt

     84,751      109,081

Other long-term liabilities

     36,547      38,303

Shareholders’ Equity

             

Common stock, par value $.01 per share – 9,500,000 shares authorized, 5,358,075 and 5,325,331 shares issued at September 30, 2004 and December 31, 2003, respectively

     54      53

Additional paid-in capital

     90,648      89,812

Retained earnings

     15,212      31

Accumulated other comprehensive income

     1,131      911
    

  

       107,045      90,807
    

  

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

   $ 299,252    $ 299,637
    

  

 

The balance sheet at December 31, 2003 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(Dollars and shares in thousands, except per share amounts)

 

     Reorganized Company

         Predecessor Company

 
    

Three Months Ended
September 30,

2004


   

Nine Months Ended
September 30,

2004


        

Three Months Ended
September 30,

2003


   

Nine Months Ended

September 30,

2003


 

Sales

   $ 76,380     $ 219,827          $ 63,232     $ 197,017  

Cost of sales

     52,693       152,173            44,552       141,240  
    


 


      


 


Gross profit

     23,687       67,654            18,680       55,777  
 

Selling, general and administrative expense

     13,576       39,675            11,908       44,211  

Employee separation and plant closure costs

     618       2,358            (147 )     882  

Loss on insolvent subsidiary

                                  13,682  

Equity loss (income) in joint venture

             51            (44 )        
    


 


      


 


       14,194       42,084            11,717       58,775  
    


 


      


 


Operating income (loss)

     9,493       25,570            6,963       (2,998 )

Other income (expense):

                                     

Gain (loss) on sale of assets

     282       (182 )          3,642       4,753  

Interest expense, net

     (1,139 )     (3,625 )          (788 )     (9,911 )

Financing costs amortization expense

                          (64 )     (1,653 )

Derivative contracts valuation (expense) income

     (77 )     (1 )          23       (389 )

Foreign currency loss

     (324 )     (52 )          (242 )     (287 )

Reorganization items, net

                          5,677       5,677  
    


 


      


 


       (1,258 )     (3,860 )          8,248       (1,810 )
    


 


      


 


Income (loss) from continuing operations before income taxes and minority interest

     8,235       21,710            15,211       (4,808 )
 

Income tax expense

     1,296       6,416            1,519       3,047  
    


 


      


 


Income (loss) from continuing operations before minority interest

     6,939       15,294            13,692       (7,855 )
 

Minority interest, net of taxes

     15       113            38       63  
    


 


      


 


Income (loss) from continuing operations

     6,924       15,181            13,654       (7,918 )
 

Income from discontinued operation, net of tax

                                  833  
    


 


      


 


Net income (loss)

   $ 6,924     $ 15,181          $ 13,654     $ (7,085 )
    


 


      


 


Net income (loss) from continuing operations per common share – basic

   $ 1.29     $ 2.84          $ 0.51     $ (0.30 )

Income from discontinued operation

                                  0.03  
    


 


      


 


Net income (loss) per common share – basic

   $ 1.29     $ 2.84          $ 0.51     $ (0.27 )
    


 


      


 


Net income (loss) from continuing operations per common share – assuming dilution

   $ 1.24     $ 2.78          $ 0.51     $ (0.30 )
                                       

Income from discontinued operation

                                  0.03  
    


 


      


 


Net income (loss) per common share – assuming dilution

   $ 1.24     $ 2.78          $ 0.51     $ (0.27 )
    


 


      


 


Shares used in per share calculations — basic

     5,357       5,349            26,627       26,336  
    


 


      


 


Shares used in per share calculations – assuming dilution

     5,565       5,455            26,627       26,336  
    


 


      


 


 

See accompanying notes to these unaudited condensed consolidated financial statements, including Note A – Basis of Preparation, describing the Reorganized Company and Predecessor Company. The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Dollars in thousands)

 

     Reorganized
Company


         Predecessor
Company


 
    

Nine Months Ended
September 30,

2004


        

Nine Months Ended

September 30,

2003


 

OPERATING ACTIVITIES

                     

Income (loss) from continuing operations

   $ 15,181          $ (7,918 )

Adjustments to reconcile income (loss) from continuing operations to net cash provided by operating activities:

                     

Reorganization items, net

                  (5,677 )

Reorganization value in excess of amounts allocable to identifiable assets

     1,277               

Loss on insolvent subsidiary

                  13,682  

Loss (gain) on sale of assets

     182            (4,753 )

Depreciation and amortization

     6,553            7,607  

Financing costs amortization

                  1,653  

Debt restructuring related fees expensed

                  6,046  

Employee stock and stock option related compensation expense

     1,799               

Equity loss in Joint Venture

     51               

Employee separation and plant closure costs

     81            456  

Deferred income taxes

     (2,136 )          5,000  

Other non-cash operating activities

     236            735  

Increase (decrease) in cash resulting from changes in operating assets and liabilities:

                     

Accounts receivable

     (1,788 )          2,486  

Inventory and other current assets

     (2,409 )          5,270  

Accounts payable and other current liabilities

     4,504            (1,527 )

Customer advances and billings in excess of contract revenue

     5,125            (3,594 )
    


      


Net Cash Provided By Operating Activities

     28,656            19,466  
 

INVESTING ACTIVITIES

                     

Capital expenditures

     (5,517 )          (1,907 )

Proceeds from sale of assets

     1,766            16,075  

Other investing activities

     889            933  
    


      


Net Cash (Used In) Provided By Investing Activities

     (2,862 )          15,101  
 

FINANCING ACTIVITIES

                     

Borrowings on revolving credit facilities

     1,360            20,359  

Payments on revolving credit facilities

     (1,360 )          (21,614 )

Principal payments on long-term debt

     (24,448 )          (1,199 )

Proceeds from sale of stock

     400               

Debt restructuring related fees paid

     (1,882 )          (12,583 )

Payments on interest rate collars

     (649 )          (759 )

Other financing activities

     (92 )          (111 )
    


      


Net Cash Used In Financing Activities

     (26,671 )          (15,907 )
    


      


Cash flow (used in) provided by continuing operations

     (877 )          18,660  

Cash flow provided by discontinued operation

                  1,592  
    


      


Net (decrease) increase in cash and cash equivalents

     (877 )          20,252  

Effect of exchange rate changes on cash

     (31 )          338  

Cash and cash equivalents at beginning of period

     18,600            7,225  
    


      


CASH AND CASH EQUIVALENTS AT END OF PERIOD

   $ 17,692          $ 27,815  
    


      


 

See accompanying notes to these unaudited condensed consolidated financial statements, including Note A – Basis of Preparation, describing the Reorganized Company and Predecessor Company. The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE A — Basis of Preparation

 

The accompanying unaudited condensed consolidated financial statements of Chart Industries, Inc. and subsidiaries (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Certain prior year amounts have been reclassified to conform to the current year presentation. Operating results for the three and nine-month periods ended September 30, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2003.

 

Nature of Operations: The Company is a leading global supplier of standard and custom-engineered products and systems serving a wide variety of low-temperature and cryogenic applications. The Company has developed an expertise in cryogenic systems and equipment, which operate at low temperatures sometimes approaching absolute zero. The majority of the Company’s products, including vacuum-insulated containment vessels, heat exchangers, cold boxes and other cryogenic components, are used throughout the liquid-gas supply chain for the purification, liquefaction, distribution, storage and use of industrial gases and hydrocarbons. Headquartered in Cleveland, Ohio, the Company has domestic operations located in seven states and an international presence in Australia, China, the Czech Republic, Germany and the United Kingdom.

 

Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation. Investments in affiliates where the Company’s ownership is between 20 percent and 50 percent, or where the Company does not have control but has the ability to exercise significant influence over operations or financial policy, are accounted for under the equity method. The Company’s Chart Heat Exchangers Limited (“CHEL”) subsidiary, which is 100 percent owned by the Company, filed for a voluntary administration under the U.K. Insolvency Act 1986, as more fully described in Note G. Because CHEL is not under the control of the Company subsequent to March 28, 2003, the unaudited condensed consolidated financial statements do not include the accounts or results of CHEL subsequent to March 28, 2003.

 

Basis of Presentation: On July 8, 2003, the Company and all of its then majority-owned U.S. subsidiaries filed voluntary petitions for reorganization relief under Chapter 11 of the U.S. Bankruptcy Code to implement an agreed upon senior debt restructuring plan through a pre-packaged plan of reorganization. None of the Company’s non-U.S. subsidiaries were included in the filing in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). On September 15, 2003, the Company (as reorganized, the “Reorganized Company” or “Reorganized Chart”) and all of its then majority-owned U.S. subsidiaries emerged from Chapter 11 proceedings pursuant to the Amended Joint Prepackaged Reorganization Plan of Chart Industries, Inc. and Certain Subsidiaries, dated September 3, 2003 (the “Reorganization Plan”), which the Bankruptcy Court confirmed by an order entered on September 4, 2003. Under the Reorganization Plan, the Company’s senior debt of $255,746 and related interest and fees of $1,861 were converted into a $120,000 secured term loan, with the balance of the existing senior debt being cancelled in return for an initial 95 percent equity ownership position in the Reorganized Company, and Chart’s $40,000 secured debtor-in-possession financing facility was amended and restated as a $40,000 post-bankruptcy secured revolving credit facility. On September 15, 2003, all of the Company’s common stock, warrants, options and other rights to acquire the Company’s common stock were cancelled, and the Company’s former stockholders received five percent of the initial equity of the Reorganized Company and the opportunity to acquire up to an additional five percent of equity through the exercise of new warrants.

 

The Company’s emergence from Chapter 11 bankruptcy proceedings resulted in a new reporting entity and the adoption of fresh-start accounting in accordance with the American Institute of Certified Public Accountants (“AICPA”) Statement of Position 90-7, “Financial Reporting by Entities in Reorganization Under the Bankruptcy Code” (“SOP 90-7”) (“Fresh-Start accounting”). The Company used September 30, 2003 as the date for adopting Fresh-Start accounting in order to coincide with the Company’s normal financial closing for the month of September 2003. Upon adoption of Fresh-Start accounting, a new reporting entity was deemed to be created and the recorded amounts of assets and liabilities were adjusted to reflect their estimated fair values. Accordingly, the reported historical financial statements of the Company prior to the adoption of Fresh-Start accounting (the “Predecessor Company”) for periods ended prior to September 30, 2003 are not necessarily comparable to those of the Reorganized Company. In this Quarterly Report on Form 10-Q, references to the Company’s three and nine-month periods ended September 30, 2003 refer to the Predecessor Company.

 

6


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE A — Basis of Preparation – Continued

 

Inventories: Inventories are stated at the lower of cost or market with cost being determined by the first-in, first-out (“FIFO”) method. The components of inventory are as follows:

 

     September 30,
2004


   December 31,
2003


Raw materials and supplies

   $ 18,530    $ 15,143

Work in process

     15,411      11,761

Finished goods

     8,237      7,884
    

  

     $ 42,178    $ 34,788
    

  

 

Revenue Recognition: For the majority of the Company’s products, revenue is recognized when products are shipped, title has transferred and collection is reasonably assured. For these products, there is also persuasive evidence of an arrangement, and the selling price to the buyer is fixed or determinable. For heat exchangers, cold boxes, liquefied natural gas fueling stations and engineered tanks, the Company uses the percentage of completion method of accounting. Earned revenue is based on the percentage that incurred costs to date bear to total estimated costs at completion after giving effect to the most current estimates. The cumulative impact of revisions in total cost estimates during the progress of work is reflected in the period in which these changes become known. Earned revenue reflects the original contract price adjusted for agreed upon claims and change orders, if any. Losses expected to be incurred on contracts in process, after consideration of estimated minimum recoveries from claims and change orders, are charged to operations as soon as such losses are known. Timing of amounts billed on contracts varies from contract to contract causing significant variation in working capital needs.

 

Product Warranties: The Company provides product warranties with varying terms and durations for the majority of its products. The Company records warranty expense in cost of sales. The changes in the Company’s

consolidated warranty reserve during the three and nine-month periods ended September 30, 2004 and 2003 are as follows:

 

     Reorganized
Company


         Predecessor
Company


 
    

Three Months Ended
September 30,

2004


        

Three Months Ended
September 30,

2003


 

Balance as of July 1

   $ 3,284          $ 3,906  

Warranty expense

     204            493  

Warranty usage

     (550 )          (596 )
    


      


Balance as of September 30

   $ 2,938          $ 3,803  
    


      


                       
                       
     Reorganized
Company


        

Predecessor

Company


 
    

Nine Months Ended
September 30,

2004


        

Nine Months Ended
September 30,

2003


 

Balance as of January 1

   $ 3,208          $ 4,032  

Warranty expense

     1,184            1,214  

Warranty usage

     (1,454 )          (1,443 )
    


      


Balance as of September 30

   $ 2,938          $ 3,803  
    


      


 

Reorganization Value in Excess of Amounts Allocable to Identifiable Assets and Other Intangible Assets: In order to apply Fresh-Start accounting for intangible assets, the Company engaged an independent valuation specialist to identify and value its intangible assets. The specialist conducted extensive interviews with the Company’s management to identify intangible assets including unpatented technology, patented technology, patents, customer base and trademarks and trade names, and used discounted cash flow techniques to estimate a total fair value of $51,983 for these intangible assets. As part of the Fresh-Start accounting adjustments, the Company wrote-off Predecessor Company goodwill of $74,977 as of September 30, 2003 and recorded an intangible asset for the reorganization value in excess of amounts allocable to identifiable assets (“Reorganization Value”) in the amount of $76,540 at September 30, 2003.

 

In September 2004, the Company reduced Reorganization Value by $1,277, in accordance with SOP 90-7, related to certain tax elections made during the finalization of its 2003 corporate tax return filed in September 2004 related to the nine-month period ended September 30, 2003, the date of adoption for Fresh-Start accounting.

 

7


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE A — Basis of Preparation – Continued

 

In accordance with Financial Accounting Standards Board (“FASB”) Statement of Financial Accounting Standards (“SFAS”) No. 141, “Business Combinations,” and SFAS No. 142, “Goodwill and Other Intangible Assets,” the Company is treating Reorganization Value similar to goodwill and does not amortize it or other indefinite lived intangible assets, but reviews them at least annually for impairment using a measurement date of October 1. The Company amortizes intangible assets that have finite useful lives over their useful lives.

 

SFAS No. 142 requires that indefinite lived intangible assets be tested for impairment and that the Reorganization Value be tested for impairment at the reporting unit level on an annual basis. Under SFAS No. 142, a company determines the fair value of any indefinite lived intangible assets, compares the fair value to its carrying value and records an impairment loss if the carrying value exceeds its fair value. Reorganization Value is treated like goodwill and is tested utilizing a two-step approach. After recording any impairment losses for indefinite lived intangible assets, a company is required to determine the fair value of each reporting unit and compare the fair value to its carrying value, including Reorganization Value, of such reporting unit (step one). If the fair value exceeds the carrying value, no impairment loss would be recognized. If the carrying value of the reporting unit exceeds its fair value, the Reorganization Value of the reporting unit may be impaired. The amount of the impairment, if any, would then be measured in step two, which compares the implied fair value of reporting unit Reorganization Value with the carrying amount of that Reorganization Value. The Company is currently in the process of conducting its 2004 annual impairment tests of Reorganization Value, trademarks and trade names as of October 1, 2004.

 

The following table displays the gross carrying amount and accumulated amortization for all intangible assets.

 

          September 30, 2004

     Estimated
Useful Life


   Gross
Carrying
Amount


   Accumulated
Amortization


    Net
Carrying
Amount


Finite-lived assets:

                          

Unpatented technology

   9 years    $ 3,305    $ (360 )   $ 2,945

Patented technology

   12 years      3,729      (353 )     3,376

Patents

   5 years      540      (100 )     440

Customer Base

   13 years      23,960      (1,996 )     21,964
         

  


 

          $ 31,534    $ (2,809 )   $ 28,725
         

  


 

Indefinite-lived intangible assets:

                          

Reorganization value in excess of amounts allocable to identifiable assets

        $ 75,263               

Trademarks and trade names

          20,449               
         

              
          $ 95,712               
         

              
          December 31, 2003

     Estimated
Useful Life


   Gross
Carrying
Amount


   Accumulated
Amortization


    Net
Carrying
Amount


Finite-lived assets:

                          

Unpatented technology

   9 years    $ 3,305    $ (90 )   $ 3,215

Patented technology

   12 years      3,729      (88 )     3,641

Patents

   5 years      540      (25 )     515

Customer Base

   13 years      23,960      (499 )     23,461
         

  


 

          $ 31,534    $ (702 )   $ 30,832
         

  


 

Indefinite-lived intangible assets:

                          

Reorganization value in excess of amounts allocable to identifiable assets

        $ 76,540               

Trademarks and trade names

          20,449               
         

              
          $ 96,989               
         

              

 

Amortization expense for finite-lived intangible assets was $702 and $388 for the three-month periods ended September 30, 2004 and 2003, respectively; $2,107 and $1,166 for the nine-month periods ended September 30, 2004 and 2003, respectively; and is estimated to be approximately $2,800 annually for fiscal years 2004 through 2008.

 

Capital Structure: On February 26, 2004, the Company sold 28,797 shares of common stock to its Chief Executive Officer at a price of $13.89 per share, which was based on the estimated enterprise value of the Company upon its

 

8


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE A — Basis of Preparation – Continued

 

emergence from bankruptcy as determined by a financial advisor. Since the closing market price of the Company’s common stock on this date was $29.00 per share, the Company recorded $435 as compensation expense in the first quarter of 2004.

 

Employee Stock Options: All of the Predecessor Company’s employee stock options (the “Old Options”) were cancelled on September 15, 2003 as part of the Reorganization Plan. Both the Predecessor Company and the Reorganized Company have elected to follow the intrinsic value method of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”) and related interpretations in accounting for employee stock options. Under APB 25, because the exercise price of the Predecessor Company’s employee stock options equaled the market price of the underlying stock on the date of grant, the Predecessor Company did not recognize compensation expense.

 

The Reorganization Plan allows for the issuance of new employee stock options to employees of the Company. On March 19, 2004, the Company granted 435,701 options to purchase shares of the Company’s new common stock (the “New Options”) with an exercise price of $13.89 per share when the closing market price of the Company’s common stock was $28.00 per share. These non-qualified stock options are exercisable for a period of 10 years and have two different vesting schedules: 319,701 options vest in equal annual installments over a four-year period and 116,000 options vest over a 45- month period commencing April 1, 2004 based upon the achievement of specific operating performance goals during that 45-month period as determined by the Compensation Committee of the Board of Directors. The 319,701 New Options on the time-based vesting schedule are being accounted for as a fixed compensatory plan under APB 25. For these options, the Company expects to record $4,313 as compensation expense over the vesting period based on the $14.11 difference between the closing market price and the exercise price on the date of grant. The 116,000 New Options on the performance-based vesting schedule are being accounted for as a variable compensatory plan under APB 25. For these options, the Company will record compensation expense over the vesting period based upon the difference between the closing market price of the Company’s stock and the exercise price at each balance sheet measurement date, and the Company’s estimate of the number of options that will ultimately vest based upon actual and estimated performance in comparison to the performance targets.

 

As of September 30, 2004, 14,000 new options on the time based vesting schedule and 14,000 new options on the performance based vesting schedule have been cancelled, and 5,000 additional New Options on the time based vesting schedule and 5,000 additional New Options on the performance based vesting schedule have been issued at the closing market price on the date of grant. The 5,000 new options with the time based vesting schedule are being accounted for as a fixed compensatory plan under APB 25. For these options, the Company will record no compensation expense since the exercise price was equal to the market price at the date of grant. The 5,000 new options with the performance based vesting schedule are being accounted for as a variable compensatory pan under APB 25 and the Company will record compensation expense using the same method as the initial 116,000 performance based options.

 

The New Options generally may not be transferred, and any shares of stock that are acquired upon exercise of the New Options generally may not be sold, transferred, assigned or disposed of except under certain predefined liquidity events or in the event of a change in control. For the three and nine-month periods ended September 30, 2004, the Company recorded $326 and $734, respectively, in compensation expense related to the time-based vesting New Options. For the three and nine-month periods ended September 30, 2004 the Company recorded $423 and $630, respectively, in compensation expense related to the performance-based vesting New Options.

 

9


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE A — Basis of Preparation – Continued

 

The Company’s pro forma disclosures showing the estimated fair value of employee stock options, amortized to expense over their vesting periods, are as follows:

 

     Reorganized Company

         Predecessor Company

 
    

Three Months Ended
September 30,

2004


   

Nine Months Ended
September 30,

2004


        

Three Months Ended
September 30,

2003


  

Nine Months Ended
September 30,

2003


 

Reported income (loss) from continuing operations

   $ 6,924     $ 15,181          $ 13,654    $ (7,918 )

Income from discontinued operation

                                 833  
    


 


      

  


Reported net income (loss)

     6,924       15,181            13,654      (7,085 )

Add: Share-based employee compensation expense included in reported net income (loss), net of related tax effect

     479       873                      

Deduct: Total share-based employee compensation expense determined under the fair value method for all awards, net of related tax effect

     (932 )     (1,971 )                    
    


 


      

  


Pro-forma net income (loss)

   $ 6,471     $ 14,083          $ 13,654    $ (7,085 )
    


 


      

  


Basic earnings per share:

                                    

Reported income (loss) from continuing operations

   $ 1.29     $ 2.84          $ 0.51    $ (0.30 )

Income from discontinued operation

                                 0.03  
    


 


      

  


Reported net income (loss)

     1.29       2.84            0.51      (0.27 )

Add: Share-based employee compensation expense included in reported net income (loss), net of related tax effect

     0.09       0.16                      

Deduct: Total share-based employee compensation expense determined under the fair value method for all awards, net of related tax effect

     (0.17 )     (0.37 )                    
    


 


      

  


Pro-forma net income (loss)

   $ 1.21     $ 2.63          $ 0.51    $ (0.27 )
    


 


      

  


Diluted earnings per share:

                                    

Reported income (loss) from continuing operations

   $ 1.24     $ 2.78          $ 0.51    $ (0.30 )

Income from discontinued operation

                                 0.03  
    


 


      

  


Reported net income (loss)

     1.24       2.78            0.51      (0.27 )

Add: Share-based employee compensation expense included in reported net income (loss), net of related tax effect

     0.09       0.16                      

Deduct: Total share-based employee compensation expense determined under the fair value method for all awards, net of related tax effect

     (0.17 )     (0.36 )                    
    


 


      

  


Pro-forma net income (loss)

   $ 1.16     $ 2.58          $ 0.51    $ (0.27 )
    


 


      

  


Weighted average shares – basic

     5,357       5,349            26,627      26,336  

Weighted average shares – assuming dilution

     5,565       5,455            26,627      26,336  

 

10


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE B — Debt and Credit Arrangements

 

On July 8, 2003, the Predecessor Company and all of its then majority-owned U.S. subsidiaries filed voluntary petitions for reorganization relief under Chapter 11 of the U.S. Bankruptcy Code to implement an agreed upon senior debt restructuring plan through a pre-packaged plan of reorganization. None of the Company’s non-U.S. subsidiaries were included in the filing in the Bankruptcy Court.

 

In conjunction with the filing of its Reorganization Plan, on July 17, 2003, the Predecessor Company entered into a debtor-in-possession credit facility (the “DIP Credit Facility”) with certain of its senior lenders. The DIP Credit Facility provided a revolving credit line of $40,000, of which $30,000 could also be used for the issuance of letters of credit. Loans under the DIP Credit Facility bore interest at rates equal to the prime rate plus 1.50 percent or LIBOR plus 2.50 percent. On August 13, 2003, the Bankruptcy Court entered a final order approving the DIP Credit Facility. The DIP Credit Facility expired on September 15, 2003, the bankruptcy consummation date.

 

On September 15, 2003, the Company and all of its then majority-owned U.S. subsidiaries emerged from Chapter 11 proceedings pursuant to the Reorganization Plan, which the Bankruptcy Court confirmed by an order entered on September 4, 2003. Under the Reorganization Plan, the Predecessor Company’s senior debt of $255,746 and related interest and fees of $1,861 were converted into a $120,000 secured term loan, with the balance of the existing senior debt being cancelled in return for an initial 95 percent equity ownership position in the Reorganized Company, and the Predecessor Company’s $40,000 secured DIP Credit Facility was amended and restated as a $40,000 post-bankruptcy secured revolving credit facility. On September 15, 2003, all of the Predecessor Company’s common stock, warrants, options and other rights to acquire the Predecessor Company’s common stock were cancelled, and the Predecessor Company’s former stockholders received five percent of the initial equity of the Reorganized Company and the opportunity to acquire up to an additional five percent of equity through the exercise of 280,281 newly issued warrants. These warrants to acquire new common stock have an exercise price of $32.97 per share and are exercisable for a period of seven years, subject to early termination in certain cases.

 

Effective September 15, 2003, the Reorganized Company entered into a new term loan agreement and revolving credit facility (collectively, the “Credit Facility”) and granted a security interest in substantially all of the assets of the Company to the agent bank as representative of the senior lenders. The Credit Facility provides a term loan of $120,000 with final maturity in 2009 and a revolving credit line of $40,000 that expires September 15, 2008, of which $30,000 may be used for the issuance of letters of credit. Under the terms of the Credit Facility, term loans bear interest, at the Company’s option, at rates equal to the prime rate plus 2.50 percent or LIBOR plus 3.50 percent and the revolving credit line bears interest, at the Company’s option, at rates equal to the prime rate plus 1.50 percent or LIBOR plus 2.50 percent. The Company is also required to pay a commitment fee of 0.375 percent per annum on the unused amount of the revolving credit line of the Credit Facility.

 

The Credit Facility contains certain covenants and conditions which impose limitations on the Company and its operating units, including a restriction on the payment of cash dividends and a requirement to meet certain financial tests and to maintain on a quarterly basis certain consolidated financial ratios, including maximum leverage (calculated as total debt divided by earnings before interest, taxes, depreciation, amortization and restructuring charges (“EBITDAR”)), minimum interest coverage ratio (calculated as EBITDAR divided by interest expense), minimum fixed charge coverage ratio (calculated as EBITDAR less capital expenditures divided by the sum of interest expense, scheduled debt payments and taxes paid), minimum EBITDAR and maximum capital expenditures. The Credit Facility also contains a feature whereby if the Company generates cash from operations above a pre-defined calculated amount, the Company is required to use a portion of that cash to make a pre-payment on the term loan portion of the Credit Facility.

 

At September 30, 2004, the Company had borrowings outstanding of $86,943 under the term loan portion of the Credit Facility and letters of credit outstanding and bank guarantees totaling $20,653 supported by the revolving credit line portion of the Credit Facility. On April 30, 2004 and September 27, 2004, the Company made voluntary pre-payments on the term loan portion of the Credit Facility for $10,000 and $12,000 respectively. These pre-payments reduced all future scheduled term loan amortization on a pro-rata basis.

 

The Predecessor Company’s senior debt credit facility required the Company to enter into two interest rate derivative contracts (collars) in March 1999 to manage interest rate risk exposure relative to term loan debt. One of these collars, with a notional amount of $20,438 at September 30, 2004, continues to be outstanding after the bankruptcy and expires in March 2006. The fair value of this collar is reported in accrued expenses and other current liabilities on the Company’s unaudited condensed consolidated balance sheet, and changes in the fair value of the collar are recorded on a quarterly basis and reported in derivative contracts valuation income (expense) in the Company’s unaudited condensed consolidated statement of operations.

 

11


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE C — Net Income (Loss) per Share

 

The calculations of basic and diluted net income (loss) per share for the three and nine-month periods ended September 30, 2004 and 2003 are set forth below. The assumed conversion of the Company’s potentially dilutive securities (employee stock options and warrants) was not dilutive for the three and nine-month periods ended September 30, 2003. As a result, the calculations of diluted net loss per share for the three and nine-month period ended September 30, 2003 set forth below do not reflect any assumed conversion.

 

     Reorganized Company

        Predecessor Company

 
    

Three Months Ended

September 30,

2004


  

Nine Months Ended
September 30,

2004


       

Three Months Ended
September 30,

2003


  

Nine Months Ended
September 30,

2003


 

Reported income (loss) from continuing operations

   $ 6,924    $ 15,181         $ 13,654    $ (7,918 )

Income from discontinued operation

                               833  
    

  

       

  


Net income (loss)

   $ 6,924    $ 15,181         $ 13,654    $ (7,085 )
    

  

       

  


Weighted-average common shares

     5,357      5,349           26,627      26,336  

Effect of dilutive securities:

                                  

Employee stock options and warrants

     208      106                     
    

  

       

  


Dilutive potential common shares

     5,565      5,455           26,627      26,336  
    

  

       

  


Reported income (loss) from continuing operations - basic

   $ 1.29    $ 2.84         $ 0.51    $ (0.30 )

Income from discontinued operation

                               0.03  
    

  

       

  


Net income (loss) per common share – basic

   $ 1.29    $ 2.84         $ 0.51    $ (0.27 )
    

  

       

  


Reported income (loss) from continuing operations - assuming dilution

   $ 1.24    $ 2.78         $ 0.51    $ (0.30 )

Income from discontinued operation

                               0.03  
    

  

       

  


Net income (loss) per common share – assuming dilution

   $ 1.24    $ 2.78         $ 0.51    $ (0.27 )
    

  

       

  


 

NOTE D — Comprehensive Income

 

The components of accumulated other comprehensive income are as follows:

 

     September 30,
2004


    December 31,
2003


 

Foreign currency translation adjustments

   1,134     914  

Minimum pension liability adjustments, net of taxes

   (3 )   (3 )
    

 

     1,131     911  
    

 

 

Comprehensive income for the three-month periods ended September 30, 2004 and 2003 was $7,604 and $13,932, respectively. Comprehensive income for the nine-month periods ended September 30, 2004 and 2003 was $15,401 and $447, respectively.

 

NOTE E — Employee Separation and Plant Closure Costs

 

During the three and nine-month periods ended September 30, 2004, the Company recorded employee separation and plant closure costs of $618 and $2,358, respectively, related to the relocation of employees from the Energy and Chemicals facility in Westborough, Massachusetts, to an office facility in Houston, Texas, the closure of the Distribution and Storage manufacturing facility in Plaistow, New Hampshire, the closure of the Biomedical manufacturing facility in Burnsville, Minnesota and general headcount reductions throughout the Company. During the three and nine-month periods ended September 30, 2004 the Company also recorded non-cash inventory valuation charges of $81, included in cost of sales for the write-off of inventory at those sites.

 

During the three and nine-month periods ended September 30, 2003, the Company recorded employee separation and plant closure costs of $(147) and $882 respectively, primarily related to the termination of various salaried employees throughout the Company, and for the closures of its Biomedical segment warehouse and sales office in Solingen, Germany, its Distribution and Storage segment manufacturing facilities in Columbus, Ohio and Denver, Colorado and its Energy and Chemicals segment manufacturing facility in Wolverhampton, United Kingdom. During the nine-month period ended September 30, 2003 the Company also recorded non-cash inventory valuation charges of $456 included in cost of sales for the write-off of inventory at those sites.

 

12


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE E — Employee Separation and Plant Closure Costs – Continued

 

The following table summarizes the Company’s employee separation and plant closure costs activity for the three and nine-month periods ended September 30, 2004 and 2003.

 

     Three Months Ended September 30, 2004 – Reorganized Company

 
     Biomedical

    Distribution
& Storage


    Energy &
Chemicals


    Corporate

    Total

 

One-time employee termination costs

   $ 111     $ 125     $ (43 )           $ 193  

Contract termination costs

                                        

Other associated costs

     99       261       70     $ (5 )     425  
    


 


 


 


 


Employee separation and plant closure costs

     210       386       27       (5 )     618  

Inventory valuation in cost of sales

     1       80                       81  
    


 


 


 


 


       211       466       27       (5 )     699  

Reserve usage

     (104 )     (576 )     (664 )     (60 )     (1,404 )
    


 


 


 


 


Change in reserve

     107       (110 )     (637 )     (65 )     (705 )

Reserves as of July 1, 2004

     192       389       2,330       527       3,438  
    


 


 


 


 


Reserves as of September 30, 2004

   $ 299     $ 279     $ 1,693     $ 462     $ 2,733  
    


 


 


 


 


     Three Months Ended September 30, 2003 – Predecessor Company

 
     Biomedical

    Distribution
& Storage


    Energy &
Chemicals


    Corporate

    Total

 

One-time employee termination costs

   $ 21     $ 162     $ 439     $ 384     $ 1,006  

Contract termination costs

     47       (1,801 )     545               (1,209 )

Other associated costs

     10       8       30       8       56  
    


 


 


 


 


Employee separation and plant closure costs

     78       (1,631 )     1,014       392       (147 )

Reserve usage

     (62 )     (390 )     (224 )     (343 )     (1,019 )
    


 


 


 


 


Change in reserve

     16       (2,021 )     790       49       (1,166 )

Reserves as of July 1, 2003

     1       2,642       1,558       490       4,691  
    


 


 


 


 


Reserves as of September 30, 2003

   $ 17     $ 621     $ 2,348     $ 539     $ 3,525  
    


 


 


 


 


     Nine Months Ended September 30, 2004 – Reorganized Company

 
     Biomedical

    Distribution
& Storage


    Energy &
Chemicals


    Corporate

    Total

 

One-time employee termination costs

   $ 303     $ 178     $ 280     $ 307     $ 1,068  

Contract termination costs

             105       145               250  

Other associated costs

     191       497       373       (21 )     1,040  
    


 


 


 


 


Employee separation and plant closure costs

     494       780       798       286       2,358  

Inventory valuation in cost of sales

     1       80                       81  
    


 


 


 


 


       495       860       798       286       2,439  

Reserve usage

     (196 )     (1,114 )     (1,287 )     (499 )     (3,096 )
    


 


 


 


 


Change in reserve

     299       (254 )     (489 )     (213 )     (657 )

Reserves as of January 1, 2004

             533       2,182       675       3,390  
    


 


 


 


 


Reserves as of September 30, 2004

   $ 299     $ 279     $ 1,693     $ 462     $ 2,733  
    


 


 


 


 


     Nine Months Ended September 30, 2003 – Predecessor Company

 
     Biomedical

    Distribution
& Storage


    Energy &
Chemicals


    Corporate

    Total

 

One-time employee termination costs

   $ 42     $ 350     $ 754     $ 384     $ 1,530  

Contract termination costs

     47       (1,604 )     756       97       (704 )

Other Associated Costs

     10       8       30       8       56  
    


 


 


 


 


Employee separation and plant closure costs

     99       (1,246 )     1,540       489       882  

Inventory valuation in cost of sales

     16       440                       456  
    


 


 


 


 


       115       (806 )     1,540       489       1,338  

Write-off due to CHEL insolvency

                     (2,976 )             (2,976 )

Reserve usage

     (328 )     (1,665 )     (1,182 )     (477 )     (3,652 )
    


 


 


 


 


Change in reserve

     (213 )     (2,471 )     (2,618 )     12       (5,290 )

Reserves as of January 1, 2003

     230       3,092       4,966       527       8,815  
    


 


 


 


 


Reserves as of September 30, 2003

   $ 17     $ 621     $ 2,348     $ 539     $ 3,525  
    


 


 


 


 


 

The employee separation and plant closure costs reserve at September 30, 2004 consists of $684 for contract termination and facility-related closure costs and $2,049 for one-time employee termination costs and other associated costs.

 

13


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE E — Employee Separation and Plant Closure Costs – Continued

 

The Company expects to record $0.4 million of employee separation and plant closure costs related to previously announced closures during the fourth quarter of 2004.

 

NOTE F — Acquisitions

 

On February 27, 2004, the Company’s Coastal Fabrication joint venture (“Coastal Fabrication”) executed an agreement to redeem the joint venture partner’s 50 percent equity interest of $289 for cash consideration of $250 and the possibility of additional consideration being paid based upon the number of direct labor manufacturing hours performed at the Company’s New Iberia, Louisiana facility during 2004 and 2005. The $39 difference between the cash consideration paid and the value of the 50 percent equity interest was recorded by Coastal Fabrication as a reduction of certain fixed assets. As a result of the elimination of the joint venture partner and the assumption of 100 percent of control by the Company, the Company has consolidated the operating results of Coastal Fabrication subsequent to February 27, 2004.

 

NOTE G — Loss on Insolvent Subsidiary

 

In March 2003, the Company completed the closure of its Wolverhampton, United Kingdom manufacturing facility, operated by CHEL, and all current heat exchanger manufacturing is now being conducted at its LaCrosse, Wisconsin facility. On March 28, 2003, CHEL filed for a voluntary administration under the U.K. Insolvency Act of 1986. CHEL’s application for voluntary administration was approved on April 1, 2003 and an administrator was appointed. In accordance with SFAS No. 94, “Consolidation of All Majority-Owned Subsidiaries,” the Company is not consolidating the accounts or financial results of CHEL subsequent to March 28, 2003 due to the assumption of control of CHEL by the insolvency administrator. Effective March 28, 2003, the Company recorded a non-cash impairment charge of $13,682 to write off its net investment in CHEL.

 

CHEL’s net pension plan obligations increased significantly prior to the closure of the Wolverhampton facility, primarily due to a decline in plan asset values and interest rates, resulting in an estimated plan deficit of $12,000 as of March 2003. Based on the Company’s financial condition, in March 2003 the Company determined not to advance funds to CHEL in amounts necessary to fund CHEL’s obligations. CHEL did not have the necessary funds to enable it to fund its net pension plan deficit, pay remaining severance due to former employees or pay other creditors. As a result, the trustees of the CHEL pension plan requested a decision to wind-up the plan from a United Kingdom pension regulatory board, which approved the wind-up as of March 28, 2003. Included in the impairment charge of $13,682 is an estimate of certain potential liabilities, including an estimate of CHEL’s net pension plan deficit. Adjustments to amounts provided may be required in subsequent periods when an analysis of the pension plan’s net deficit on a wind-up basis is ultimately completed by the administrator.

 

As of September 30, 2004, the Company is unable to determine the final financial impact of the April 1, 2003 approval of insolvency administration for CHEL and the related wind-up of CHEL’s United Kingdom pension plan. Additionally, the Company can provide no assurance that claims will not be asserted against the Company for obligations of CHEL related to these matters. To the extent the Company has significant financial obligations as a result of CHEL’s insolvency and the pension plan wind-up, such liability could have a material adverse impact on the Company’s liquidity and its financial position.

 

NOTE H – Income Taxes

 

The Company’s income tax expense for the three and nine-month periods ended September 30, 2004 includes a tax benefit of $1,358 representing the recognition of deferred tax assets related to certain tax elections made in the third quarter of 2004, items associated with the finalization of the 2003 corporate tax return filed in September 2004 and the reversal of certain income tax accruals based upon events occurring in the third quarter of 2004.

 

NOTE I – Discontinued Operation and Assets Held for Sale

 

On July 3, 2003, the Company sold certain assets and liabilities of its former Greenville Tube, LLC stainless steel tubing business, which the Company previously reported as a component of its Energy and Chemicals operating segment. In accordance with SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Company has classified the operating results of this business as a discontinued operation on its consolidated statements of operations for the nine-month period ended September 30, 2003. The amount of revenue reported in discontinued operations was $8,807 for the nine-month period ended September 30, 2003. The amount of pre-tax profit reported in discontinued operations was $833 for the nine-month period ended September 30, 2003 and is equal to the income from discontinued operation, net of income taxes, since the Company did not allocate income tax expense to this business.

 

In September 2003, the Company decided to sell a vacant building and a parcel of land at its New Prague, Minnesota Distribution and Storage manufacturing facility and classified $550 for the value of these assets as held for sale on its condensed consolidated balance sheet as of December 31, 2003. These assets were sold in April 2004 for $550 and the Company recorded a loss of $11 due to selling expenses. The net proceeds from this sale were used for working capital purposes.

 

14


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE I – Discontinued Operation and Assets Held for Sale – Continued

 

In January 2004, the Company decided to sell a building and parcel of land at its Burnsville, Minnesota Biomedical manufacturing and office facility, and classified $4,628 for the value of the land and building related to the Burnsville facility as assets held for sale on its unaudited condensed consolidated balance sheet as of March 31, 2004. In June 2004, the Company executed an agreement to sell the Burnsville facility for $4,500. Because the net sales price, estimated to be $4,175 after selling costs, is lower than the carrying value, the assets held for sale have been written down to the net sales price by recording a $453 loss on sale of assets in the second quarter of 2004. The sale closed on October 14, 2004 with no significant differences compared to the initial estimated net selling price. The net proceeds from this sale were used to pay down $880 of debt outstanding under an industrial revenue bond and the balance is available for working capital purposes.

 

In June 2004, the Company decided to sell a building, parcel of land and manufacturing equipment at its Plaistow, New Hampshire Distribution and Storage manufacturing and office facility. The manufacturing equipment was sold in August 2004 for $1,082 resulting in a gain on sale of assets of $549. In September 2004, the Company executed an agreement to sell the Plaistow land and building for $3,800. Because the net sales price, estimated to be $3,567 after selling costs, is lower that the carrying value the asset has been written down to the net sales price by recording a $386 loss on sale of assets in the third quarter of 2004. The Plaistow facility is classified as held for sale on its unaudited condensed consolidated balance sheet as of September 30, 2004. The sale is not expected to close until the second quarter of 2005. The net proceeds from this sale are expected to be available for working capital purposes.

 

NOTE J — Employee Benefit Plans

 

The Company has four defined benefit pension plans covering certain U.S. hourly and salary employees. Two of these plans are frozen and two are active. In October 2004, the Company decided to freeze a third plan effective December 31, 2004. The defined benefit plans provide benefits based primarily on the participants’ years of service and compensation.

 

In December 2002, the Company announced the planned closure of its Wolverhampton, United Kingdom manufacturing facility, which was completed in March 2003. This closure resulted in the termination in 2003 of substantially all employees of this facility and eliminated for the terminated employees the accrual of defined benefits for any future service under the United Kingdom defined benefit pension plan (the “U.K. Plan”).

 

Due to the U.K. Plan being terminated and an insolvency administrator controlling CHEL and the U.K. Plan, the Company has been unable to obtain any actuarial valuation or plan asset information subsequent to December 31, 2002. As a result, the Company did not record any additional periodic pension cost in 2004 or 2003 related to the U.K. Plan, and continues to have recorded a net pension liability of $2,386 for the U.K. Plan at September 30, 2004. The Company can provide no assurance that claims will not be asserted against the Company for pension or other obligations of CHEL related to these matters. To the extent the Company has significant financial obligations as a result of CHEL’s insolvency and the pension plan wind-up, such liability could have a material adverse impact on the Company’s liquidity and its financial position.

 

The following table sets forth the components of net periodic pension cost for the three and nine-month periods ended September 30, 2004 and 2003.

 

     Reorganized Company

         Predecessor Company

 
    

Three Months Ended
September 30,

2004


   

Nine Months Ended
September 30,

2004


        

Three Months Ended
September 30,

2003


   

Nine Months Ended
September 30,

2003


 

Service cost

   $ 90     $ 665          $ 185     $ 851  

Interest cost

     452       1,542            329       1,515  

Expected return on plan assets

     (523 )     (1,601 )          (260 )     (1,197 )

Amortization of net gain

                          94       431  

Amortization of prior service cost

                          18       83  

Recognized net actuarial gain

     (36 )     (36 )                     
    


 


      


 


Total pension (income) cost

   $ (17 )   $ 570          $ 366     $ 1,683  
    


 


      


 


 

NOTE K — Operating Segments

 

The Company’s reportable segments are business units that offer different products. The reportable segments are each managed separately because they manufacture and distribute distinct products with different production processes and sales and marketing approaches. The Biomedical segment sells medical products, biological storage systems, magnetic resonance imaging (“MRI”) cryostat components and telemetry products. The Distribution and Storage segment sells cryogenic bulk storage systems, cryogenic packaged gas systems, cryogenic systems and components, beverage liquid CO2 systems and cryogenic services to various companies for the storage and transportation of both industrial and natural gases. The Energy and Chemicals segment sells heat exchangers, cold boxes and liquefied natural gas (“LNG”) alternative fuel systems to

 

15


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

NOTE K — Operating Segments – Continued

 

natural gas, petrochemical processing and industrial gas companies who use them for the liquefaction and separation of natural and industrial gases. Due to the nature of the products that each operating segment sells, there are no inter-segment sales.

 

The Company evaluates performance and allocates resources based on profit or loss from operations before gain (loss) on sale of assets, net interest expense, financing costs amortization expense, derivative contracts valuation (expense) income, foreign currency loss, income taxes and minority interest.

 

Information for the Company’s three reportable segments and its corporate headquarters is presented below:

 

     Reorganized Company

 
     Three Months Ended September, 2004

 
     Biomedical

  

Distribution

and Storage


  

Energy

and Chemicals


    Corporate

    Total

 

Sales

   $ 18,998    $ 41,038    $ 16,344             $ 76,380  

Operating income (loss)(A)(B)(C)(D)

     3,789      7,672      2,333     $ (4,301 )     9,493  
     Predecessor Company

 
     Three Months Ended September 30, 2003

 
     Biomedical

   Distribution
and Storage


  

Energy

and Chemicals


    Corporate

    Total

 

Sales

   $ 17,172    $ 30,382    $ 15,678             $ 63,232  

Operating income (loss) (E) (F) (G)

     4,712      3,451      1,265     $ (2,465 )     6,963  
     Reorganized Company

 
     Nine Months Ended September, 2004

 
     Biomedical

  

Distribution

and Storage


  

Energy

and Chemicals


    Corporate

    Total

 

Sales

   $ 55,643    $ 110,409    $ 53,775             $ 219,827  

Operating income (loss)(A)(B)(C)(D)

     11,463      20,411      6,368     $ (12,672 )     25,570  
     Predecessor Company

 
     Nine Months Ended September 30, 2003

 
     Biomedical

   Distribution
and Storage


  

Energy

and Chemicals


    Corporate

    Total

 

Sales

   $ 51,638    $ 94,895    $ 50,484             $ 197,017  

Operating income (loss) (E) (F) (G)

     12,381      8,773      (9,463 )   $ (14,689 )     (2,998 )

(A) Biomedical operating income for the three and nine-month periods ended September 30, 2004 includes $210 and $494, respectively, of employee separation and plant closure costs primarily related to the closure of the Company’s Burnsville, Minnesota manufacturing facility.
(B) Distribution and Storage operating income for the three and nine-month periods ended September 30, 2004 includes $386 and $780, respectively, of employee separation and plant closure costs and $80 for the three and nine-month periods ended September 30, 2004 in inventory valuation charges primarily related to the closure of the Company’s Plaistow, New Hampshire manufacturing facility.
(C) Energy and Chemicals operating income for the three and nine-month periods ended September 30, 2004 includes $27 and $798, respectively, of employee separation and plant closure costs related primarily to the relocation of employees from the facility in Westborough, Massachusetts, to an office facility in Houston, Texas. Energy and Chemicals operating income for the nine-month period ended September 30, 2004 includes the significant positive impact of a premium-priced expedited heat exchanger order that was recorded, completed and shipped entirely during the first quarter.

 

16


Table of Contents

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements — September 30, 2004

(Dollars and shares in thousands, except per share amounts)

 

(D) Corporate operating loss for the three and nine-month periods ended September 30, 2004 includes $(5) and $286, respectively, of employee separation and plant closure (income) costs primarily related to headcount reductions and $749 and $1,364, respectively, of stock compensation expense related to the March 19, 2004 issuance of stock options. Corporate operating loss for the nine-month period ended September 30, 2004 includes $435 for compensation expense resulting from the sale of the Company’s common stock to the Company’s Chief Executive Officer at a price below the closing market price of the stock on the date of the sale.
(E) Distribution and Storage operating income for the three and nine-month period ended September 30, 2003 includes $(1,631) and $(1,246) of employee separation and plant closure (income) costs and $440 for the nine-month period ended September 30, 2003 in inventory valuation charges primarily related to the closure of the Company’s Denver, Colorado, Costa Mesa, California and Columbus, Ohio manufacturing facilities.
(F) Energy and Chemicals operating income (loss) for the three and nine-month periods ended September 30, 2003 includes $1,014 and $1,540, respectively, of employee separation and plant closure costs primarily related to the closure of the Company’s CHEL manufacturing facility and $13,682 for the nine months ended September 30, 2003 of charges related to the write-off the Company’s net investment in CHEL.
(G) Corporate operating loss for the three and nine-month periods ended September 30, 2003 includes $392 and $489, respectively, of employee separation and plant closure costs primarily related to headcount reductions and $854 and $6,046, respectively, of professional fees incurred related to the Company’s debt restructuring initiatives.

 

17


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Nature of Operations

 

The Company is a leading global supplier of standard and custom-engineered products and systems serving a wide variety of low-temperature and cryogenic applications. The Company has developed an expertise in cryogenic systems and equipment, which operate at low temperatures sometimes approaching absolute zero. The majority of the Company’s products, including vacuum-insulated containment vessels, heat exchangers, cold boxes and other cryogenic components, are used throughout the liquid-gas supply chain for the purification, liquefaction, distribution, storage and use of industrial gases and hydrocarbons. Headquartered in Cleveland, Ohio, the Company has domestic operations located in seven states and an international presence in Australia, China, the Czech Republic, Germany and the United Kingdom.

 

Chapter 11 Filing and Emergence

 

On July 8, 2003, the Company and all of its then majority-owned U.S. subsidiaries filed voluntary petitions for reorganization relief under Chapter 11 of the U.S. Bankruptcy Code to implement an agreed upon senior debt restructuring plan through a pre-packaged plan of reorganization. None of the Company’s non-U.S. subsidiaries were included in the filing in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). On September 15, 2003, the Company (as reorganized, the “Reorganized Company” or “Reorganized Chart”) and all of its then majority-owned U.S. subsidiaries emerged from Chapter 11 proceedings pursuant to the Amended Joint Prepackaged Reorganization Plan of Chart Industries, Inc. and Certain Subsidiaries, dated September 3, 2003 (the “Reorganization Plan”), which the Bankruptcy Court confirmed by an order entered on September 4, 2003. Under the Reorganization Plan, the Company’s senior debt of $255.7 million and related interest and fees of $1.9 million were converted into a $120.0 million secured term loan, with the balance of the existing senior debt being cancelled in return for an initial 95 percent equity ownership position in the Reorganized Company, and Chart’s $40.0 million secured debtor-in-possession financing facility was amended and restated as a $40.0 million post-bankruptcy secured revolving credit facility. On September 15, 2003, all of the Company’s common stock, warrants, options and other rights to acquire the Company’s common stock were cancelled, and the Company’s former stockholders received five percent of the initial equity of the Reorganized Company and the opportunity to acquire up to an additional five percent of equity through the exercise of new warrants.

 

Under the Reorganization Plan, the Company’s former stockholders were entitled to receive their respective shares of Reorganized Chart common stock, par value $.01 per share (“New Common Stock”), and warrants to purchase New Common Stock (“New Warrants” and together with New Common Stock, “New Equity”) upon surrendering to the Company their stock certificates representing the cancelled Company common stock no later than September 15, 2004 in accordance with written instructions distributed by the Company. The terms of the Reorganization Plan required that any certificates representing cancelled common stock be surrendered by September 15, 2004 and provided that all New Equity held for distribution to the holders of such certificates that were not surrendered by September 15, 2004 be cancelled and of no further force or effect. On September 16, 2004, 1,431 shares of New Common Stock and 1,519 New Warrants were cancelled in accordance with these terms of the Reorganization Plan.

 

The Company’s emergence from Chapter 11 bankruptcy proceedings resulted in a new reporting entity and the adoption of fresh-start accounting in accordance with the American Institute of Certified Public Accountants (“AICPA”) Statement of Position 90-7, “Financial Reporting by Entities in Reorganization Under the Bankruptcy Code” (“SOP 90-7”) (“Fresh-Start accounting”). The Company used September 30, 2003 as the date for adopting Fresh-Start accounting in order to coincide with the Company’s normal financial closing for the month of September 2003. Upon adoption of Fresh-Start accounting, a new reporting entity was deemed to be created and the recorded amounts of assets and liabilities were adjusted to reflect their estimated fair values. Accordingly, the reported historical financial statements of the Company prior to the adoption of Fresh-Start accounting (the “Predecessor Company”) for periods ended prior to September 30, 2003 are not necessarily comparable to those of the Reorganized Company. In this Quarterly Report on Form 10-Q, references to the Company’s three and nine-month periods ended September 30, 2003 and all periods ended prior to September 30, 2003 refer to the Predecessor Company.

 

Overview

 

Due to the extended periods of time from receipt of customer orders to final completion and shipment of products, particularly in the Energy and Chemicals segment, the Company believes that signed customer orders are a significant indicator of its future financial performance. As a result, the Company measures and internally reports orders on a daily basis in an effort to stay current with market trends and make corresponding timely decisions regarding material purchases, headcount and other operating issues. The Company booked orders of $79.5 million in the third quarter of 2004, compared with $88.3 million in the second quarter of 2004 and $101.1 million in the first quarter of 2004. The Company’s third quarter 2004 orders, although down from the level achieved in the first two quarters of 2004, which included a significant LNG systems order from Bechtel in the first quarter, were particularly strong in the Biomedical and Distribution and Storage segments. The Company expects orders for the fourth quarter of 2004 to be approximately $100 million, which includes a significant order received in October 2004 for $20.4 million in the Energy and Chemicals segment. Management believes that the Company’s strong order performance over the last three quarters is an indicator that the Company’s markets have recovered and are stronger in 2004 than in the past two fiscal years.

 

18


Table of Contents

The Company’s third quarter 2004 operating results, when compared to the third quarter of 2003, reflect continued market improvements and operating cost reductions in the Company’s Distribution and Storage operating segment, continued strong performance in the Biomedical segment and slightly stronger sales in the Energy and Chemicals segment. Gross profit margin and margin percentage in the third quarter of 2004 increased over the third quarter of 2003, due to improved market pricing and the favorable impact of the Company’s operational restructuring initiatives, particularly in the Distribution and Storage segment.

 

During the third quarter of 2004, the Company continued its operational restructuring initiatives by completing the closures of its Plaistow, New Hampshire engineered tank manufacturing facility during the third quarter of 2004 and expects to complete the closure of its Burnsville, Minnesota Biomedical manufacturing facility during the first quarter of 2005. The Company is transferring manufacturing operations from these closed facilities to its New Prague, Minnesota and Canton, Georgia manufacturing facilities, respectively. The Company will continue to record employee separation and plant closure costs for the remainder of 2004 and into 2005 as it completes these activities. Management believes these operational restructuring efforts should position the Company for additional improvements in operating performance and enable the Company to better weather future downturns in its markets.

 

As a result of the operational restructuring activities, the apparent recovery of the markets served by the Energy and Chemicals and Distribution and Storage segments and the Company’s performance over the first nine months of 2004, the Company believes it is well positioned for sales and earnings growth in 2004 in comparison to the very challenging year ended December 31, 2003. Management believes the Company will be able to operate during the remainder of 2004 within the covenant constraints and payment obligations of its current credit agreements, with its efforts directed toward enhancing stockholder value.

 

Results of Operations for the Three and Nine-Month Periods Ended September 30, 2004 and 2003

 

The following table sets forth sales, gross profit and gross profit margin for the Company and its three operating segments for the three and nine-month periods ended September 30, 2004 and 2003.

 

     Reorganized Company

         Predecessor Company

 
    

Three Months Ended

September 30,

2004


   

Nine Months Ended

September 30,

2004


        

Three Months Ended
September 30,

2003


   

Nine Months Ended

September 30,

2003


 
     (Dollars in thousands)  

Sales

                                     

Biomedical

   $ 18,998     $ 55,643          $ 17,172     $ 51,638  

Distribution and Storage

     41,038       110,409            30,382       94,895  

Energy and Chemicals

     16,344       53,775            15,678       50,484  
    


 


      


 


Total

   $ 76,380     $ 219,827          $ 63,232     $ 197,017  
    


 


      


 


Gross Profit

                                     

Biomedical

   $ 6,605     $ 19,524          $ 6,253     $ 17,579  

Distribution and Storage

     12,261       33,260            7,999       24,112  

Energy and Chemicals

     4,821       14,870            4,428       14,086  
    


 


      


 


Total

   $ 23,687     $ 67,654          $ 18,680     $ 55,777  
    


 


      


 


Gross Profit Margin

                                     

Biomedical

     34.8 %     35.1 %          36.4 %     34.0 %

Distribution and Storage

     29.9 %     30.1 %          26.3 %     25.4 %

Energy and Chemicals

     29.5 %     27.7 %          28.2 %     27.9 %

Total

     31.0 %     30.8 %          29.5 %     28.3 %

 

Sales for the third quarter of 2004 were $76.4 million versus $63.2 million for the third quarter of 2003, an increase of $13.2 million, or 20.8 percent. Biomedical segment sales of $19.0 million in the third quarter of 2004 increased $1.8 million, or 10.6 percent, compared with sales of $17.2 million in the third quarter of 2003. Sales of medical and biological storage systems products increased $2.2 million and $0.2 million, respectively, on higher volume, while sales of MRI products decreased $0.6 million compared with the third quarter of 2003 on lower volume to this product line’s one customer. Distribution and Storage segment sales in the third quarter of 2004 increased 35.1 percent to $41.0 million, compared with $30.4 million for the same quarter in 2003. Sales of bulk storage systems increased by $8.6 million and packaged gas systems increased $2.1 million compared with the third quarter of 2003. The Company has continued to increase its product pricing in the Distribution and Storage segment to offset increased materials costs due primarily to steel surcharges. Energy and Chemicals segment sales were $16.3 million in the third quarter of 2004 compared with sales of $15.7 million in the third quarter of 2003, an increase of 4.2 percent. Sales of heat exchangers and LNG alternative fuel systems increased $0.2 million and $1.4 million, respectively due to higher volume.

 

19


Table of Contents

Sales for the first nine months of 2004 were $219.8 million versus $197.0 million for the first nine months of 2003, an increase of $22.8 million, or 11.6 percent. Biomedical segment sales increased 7.8 percent to $55.6 million in the first nine months of 2004, compared with sales of $51.6 million in the first nine months of 2003. Medical products and biological storage systems sales increased $5.4 million and $0.9 million, respectively, on increased volume while sales of MRI products were down $2.3 million due to lower volume. Distribution and Storage segment sales increased 16.3 percent primarily due to significant market improvement for industrial bulk storage systems, with sales of $110.4 million for the first nine months of 2004, compared with $94.9 million for the same nine-month period in 2003. Energy and Chemicals segment sales increased 6.5 percent, with sales of $53.8 million in the first nine months of 2004 compared with sales of $50.5 million in the first nine months of 2003. Sales of heat exchangers and LNG alternative fuel systems increased $3.0 million and $0.3 million, respectively, due to higher volume.

 

Gross profit for the third quarter of 2004 was $23.7 million versus $18.7 million for the third quarter of 2003. Gross profit margin for the third quarter of 2004 was 31.0 percent versus 29.5 percent for the third quarter of 2003. Gross profit for the first nine months of 2004 was $67.7 million versus $55.8 million for the first nine months of 2003. Gross profit margin for the first nine months of 2004 was 30.8 percent versus 28.3 percent for the first nine months of 2003. Gross profit and gross profit margin improved for the three and nine-month periods ended September 30, 2004 in the Biomedical segment due to increased volume and in the Distribution and Storage segment primarily due to significantly higher volumes, increases in product pricing and the realization of operational savings from the Company’s manufacturing facility consolidation plan. Gross profit and gross profit margin in the Energy and Chemicals segment stayed relatively flat.

 

Selling, general and administrative (“SG&A”) expense for the third quarter of 2004 was $13.6 million versus $11.9 million for the third quarter of 2003. As a percentage of sales, SG&A expense was 17.8 percent for the third quarter of 2004 versus 18.8 percent for the third quarter of 2003. The Company recorded $0.7 million, or 1.0 percent of sales, of SG&A expense in the third quarter of 2004 for compensation expense related to the new stock options issued on March 19, 2004. The Company recorded $0.9 million, or 1.4 percent of sales, of SG&A expense in the third quarter of 2003 for fees paid to professional advisors related to the Company’s successful efforts to restructure its senior debt and exit from bankruptcy. The increase in SG&A expense for the third quarter of 2004 was a result of higher amortization costs caused by the revaluation of intangible assets as part of Fresh-Start Accounting procedures and an increase in incentive performance costs due to the Company’s improved performance in 2004.

 

SG&A expense for the first nine months of 2004 was $39.7 million versus $44.2 million for the first nine months of 2003. As a percentage of sales, SG&A expense was 18.0 percent for the first nine months of 2004 versus 22.4 percent for the first nine months of 2003. The Company recorded $1.8 million, or 0.8 percent of sales, of SG&A expense in the first nine months of 2004 for compensation expense resulting from the sale of 28,797 shares of the Company’s common stock to its Chief Executive Officer at a price below the closing market price on the date of sale and the issuance of new stock options to certain key employees. The Company recorded $6.0 million, or 3.1 percent of sales, of SG&A expense in the first nine months of 2003 for fees paid to professional advisors related to the Company’s successful efforts to restructure its senior debt. The decrease in SG&A expense for the nine-month period ended September 30, 2004 was a result of operational savings due to the Company’s restructuring efforts.

 

During 2003 and into 2004, the Company continued its manufacturing facility reduction plan and engaged restructuring consultants to assist in the selection of other facilities to close and the implementation of these closure activities. These actions resulted in the September 2003 closure of the Company’s Energy and Chemicals segment sales and engineering office in Westborough, Massachusetts and the announcements in December 2003 and January 2004 of the closure of the Company’s Distribution and Storage segment manufacturing facility in Plaistow, New Hampshire and the Biomedical segment manufacturing and office facility in Burnsville, Minnesota, respectively. In each of these facility closures, the Company is not exiting the product lines manufactured at those sites, but is moving manufacturing to other facilities with available capacity, most notably New Prague, Minnesota for engineered tank production and Canton, Georgia for medical production. The Plaistow facility closure was completed in the third quarter of 2004. The Company expects to incur capital expenditures in 2004 of approximately $1.5 million for improvements and additions to the Canton, Georgia facility, and expects to substantially complete the closure of the Burnsville facility in the first quarter of 2005. These facility closures are expected to result in an additional $0.4 million of employee separation and plant closure costs in the fourth quarter of 2004, and should better position these segments going forward.

 

During the three and nine-month periods ended September 30, 2004, the Company recorded $0.6 million and $2.4 million, respectively, of employee separation and plant closure costs, primarily related to the closure of the Plaistow, New Hampshire and Burnsville, Minnesota facilities and the final steps in the transition of employees out of the closed Westborough, Massachusetts engineering office. In July 2004, the Company entered into an agreement to sell its Burnsville, Minnesota facility for gross proceeds of $4.5 million and the sale was completed in October, 2004. The land and building related to the Burnsville facility are included in assets held for sale in the Company’s unaudited condensed consolidated balance sheet as of September 30, 2004. The proceeds of this sale were used to pay down $0.9 million of debt outstanding under an industrial revenue bond in the third quarter and the balance is available for working capital purposes. During the three and nine-month periods ended September 30, 2004, the Company recorded a $0.5 million loss on the sale of assets related to adjusting the Burnsville, Minnesota land and buildings to fair value less costs to sell based upon the

 

20


Table of Contents

executed sales agreement. In April 2004, the Company sold for $0.6 million cash proceeds a vacant building and a parcel of land at its New Prague facility that was classified as held for sale in the Company’s condensed consolidated balance sheet as of December 31, 2003 included in this Quarterly Report on Form 10-Q. In August 2004, the Company sold for $1.1 million cash proceeds equipment at its Plaistow facility resulting in a $0.6 million gain on the sale of assets. The Company entered into an agreement to sell the Plaistow land and building for gross proceeds of $3.6 million and expects to complete the sale in the second quarter of 2005. The Company recorded a $0.4 million loss on the sale of assets related to adjusting the Plaistow land and building to fair value less cost to sell based upon the executed agreement. The land and building related to the Plaistow facility are included in assets held for sale on the Company’s unaudited condensed consolidated balance sheet as of September 30, 2004. The proceeds from this sale are expected to be available for working capital purposes.

 

During the third quarter and first nine months of 2003, the Company recorded $(0.1) million and $0.9 million, respectively, of employee separation and plant closure costs primarily related to the final steps of the closures of its Wolverhampton, U.K. heat exchanger manufacturing facility and its Columbus, Ohio Distribution and Storage manufacturing facility. The Company recorded a $3.6 million and $4.8 million gain on the sale of assets in the third quarter and first nine-months of 2003, respectively, related to the sale of various fixed assets of the closed Columbus, Ohio facility and the sale of certain assets and liabilities of its former Greenville Tube, LLC stainless steel tubing business.

 

The Company recorded $0.05 million of equity loss in its Coastal Fabrication joint venture (“Coastal Fabrication”) in the first nine months of 2004 compared with $0.04 million and $0.0 million of equity income for the three and nine-month month period ended September 30, 2003, respectively. On February 27, 2004, Coastal Fabrication executed an agreement to redeem the joint venture partner’s 50 percent equity interest of $0.29 million for cash consideration of $0.25 million and the possibility of additional consideration being paid based upon the number of direct labor manufacturing hours performed at the Company’s New Iberia, Louisiana facility during 2004 and 2005. The $0.04 million difference between the cash consideration paid and the value of the 50 percent equity interest was recorded by Coastal Fabrication as a reduction of certain fixed assets. As a result of the elimination of the joint venture partner and the assumption of 100 percent of control by the Company, the Company has consolidated the operating results of Coastal Fabrication subsequent to February 27, 2004.

 

In March 2003, the Company completed the closure of its Wolverhampton, United Kingdom manufacturing facility, operated by Chart Heat Exchangers Limited (“CHEL”), and all current heat exchanger manufacturing is now being conducted at its La Crosse, Wisconsin facility. On March 28, 2003, CHEL filed for a voluntary administration under the U.K. Insolvency Act of 1986. CHEL’s application for voluntary administration was approved on April 1, 2003 and an administrator was appointed. In accordance with SFAS No. 94, “Consolidation of All Majority-Owned Subsidiaries,” the Company is not consolidating the accounts or financial results of CHEL subsequent to March 28, 2003 due to the assumption of control of CHEL by the insolvency administrator. Effective March 28, 2003, the Company recorded a non-cash impairment charge of $13.7 million to write off its net investment in CHEL. Included in the impairment charge of $13.7 million is an estimate of certain potential liabilities, including an estimate of CHEL’s net pension plan deficit. Adjustments to amounts provided may be required in subsequent periods when an analysis of the pension plan’s net deficit on a wind-up basis is ultimately completed by the administrator.

 

As of September 30, 2004, the Company is unable to determine the final financial impact of the April 1, 2003 approval of insolvency administration for CHEL and the related wind-up of CHEL’s United Kingdom pension plan. Additionally, the Company can provide no assurance that claims will not be asserted against the Company for obligations of CHEL related to these matters. To the extent the Company has significant financial obligations as a result of CHEL’s insolvency and the pension plan wind-up, such liability could have a material adverse impact on the Company’s liquidity and its financial position.

 

Net interest expense for the third quarter and first nine months of 2004 was $1.1 million and $3.6 million, respectively, versus $0.8 million and $9.9 million, respectively, for the third quarter and first nine months of 2003, reflecting the Company’s decreased leverage position that resulted from the bankruptcy reorganization and repayment of debt. The Company’s one remaining interest rate collar covering $20.4 million of the senior term loan outstanding at September 30, 2004 expires in March 2006. The Company recorded $0.08 million and $0.01 million of derivative contracts valuation expense in the third quarter and first nine months of 2004 compared with $0.02 million of derivative contracts valuation income and $0.39 million of derivative contracts valuation expense in the third quarter and first nine months of 2003, respectively, related to marking the fair value of the collar to market on a quarterly basis.

 

Income tax expense of $1.3 million and $6.4 million in the third quarter and first nine months of 2004, respectively, represents taxes on both domestic and foreign earnings at an estimated annual effective income tax rate of 36 percent. Income tax expense of $1.5 million and $3.0 million in the third quarter and first nine months of 2003, respectively, represents taxes on earnings of foreign subsidiaries. The Company’s income tax expense for the three and nine-month periods ended September 30, 2004 includes a tax benefit of $1.3 million, representing the recognition of deferred tax assets related to certain tax elections made in the third quarter of 2004, items associated with the finalization of the 2003 corporate tax return filed in September 2004 and the reversal of certain income tax accruals determined to not be required based upon events occurring in the third quarter of 2004

 

21


Table of Contents

As a result of the foregoing, the Company reported net income for the third quarter of 2004 of $6.9 million, or $1.24 per diluted share, versus net income of $13.7 million, or $0.51 per diluted share, for the third quarter of 2003. The Company reported net income for the first nine months of 2004 of $15.2 million, or $2.78 per diluted share, versus a net loss of $7.1 million, or $0.27 per diluted share, for the first nine months of 2003.

 

Liquidity and Capital Resources

 

Debt Instruments and Related Covenants: On July 8, 2003, the Company and all of its then majority-owned U.S. subsidiaries filed voluntary petitions for reorganization relief under Chapter 11 of the U.S. Bankruptcy Code to implement an agreed upon senior debt restructuring plan through a pre-packaged plan of reorganization. In conjunction with the filing of its Reorganization Plan, on July 17, 2003, the Company entered into a debtor-in-possession credit facility (the “DIP Credit Facility”) with certain of its senior lenders. The DIP Credit Facility provided a revolving credit line of $40.0 million, of which $30.0 million could also be used for the issuance of letters of credit. On August 13, 2003, the Bankruptcy Court entered a final order approving the DIP Credit Facility. The Company issued certain letters of credit but did not borrow any funds under the DIP Credit Facility, which matured on September 15, 2003, the bankruptcy consummation date.

 

On September 15, 2003, the Company and all of its then majority-owned U.S. subsidiaries emerged from Chapter 11 proceedings pursuant to the Reorganization Plan, which the Bankruptcy Court confirmed by an order entered on September 4, 2003. Effective September 15, 2003, the Company entered into a term loan agreement and revolving credit facility (collectively, the “Credit Facility”) and granted a security interest in substantially all of the assets of the Company to the agent bank as representative of the senior lenders. The Credit Facility provides a term loan of $120.0 million with final maturity in 2009 and a revolving credit line of $40.0 million that expires on September 15, 2008, of which $30.0 million may be used for the issuance of letters of credit. Under the terms of the Credit Facility, term loans bear interest, at the Company’s option, at rates equal to the prime rate plus 2.50 percent or LIBOR plus 3.50 percent and the revolving credit line bears interest, at the Company’s option, at rates equal to the prime rate plus 1.50 percent or LIBOR plus 2.50 percent. The Company is also required to pay a commitment fee of 0.375 percent per annum on the unused amount of the revolving credit line of the Credit Facility.

 

The Credit Facility contains certain covenants and conditions which impose limitations on the Company and its operating units, including a restriction on the payment of cash dividends and a requirement to meet certain financial tests and to maintain on a quarterly basis certain consolidated financial ratios, including maximum leverage (calculated as total debt less cash divided by earnings before interest, taxes, depreciation, amortization and restructuring charges (“EBITDAR”)), minimum interest coverage ratio (calculated as EBITDAR divided by interest expense), minimum fixed charge coverage ratio (calculated as EBITDAR less capital expenditures divided by the sum of interest expense, scheduled debt payments and taxes paid), minimum EBITDAR and maximum capital expenditures. The Credit Facility also contains a feature whereby if the Company generates cash from operations above a pre-defined calculated amount, the Company is required to use a portion of that cash to make a pre-payment on the term loan portion of the Credit Facility.

 

At September 30, 2004, the Company had borrowings outstanding of $86.9 million under the term loan portion of the Credit Facility and letters of credit outstanding and bank guarantees totaling $20.7 million supported by the revolving credit line portion of the Credit Facility.

 

Sources and Use of Cash: Cash provided by operations in the first nine months of 2004 was $28.7 million compared with $19.5 million provided in the first nine months of 2003. The Company’s successful reorganization under the Bankruptcy Code enabled it to return to normal payment terms with most of its vendors, rather than the cash on delivery and other accelerated payment terms the Company was required to use in 2003, and allowed the Company to request and receive favorable progress billing terms on many large projects. Additional efforts to improve the timeliness of accounts receivable cash collections on an increased level of sales, combined with the improved operations of the Company, contributed to the positive cash flow and cash provided by working capital improvements that occurred in the first nine months of 2004. Management believes the Company will continue to generate sufficient positive cash flow to fund operations, capital expenditures and working capital requirements throughout 2004 without utilizing the revolving loan portion of its domestic Credit Facility.

 

Capital expenditures in the first nine months of 2004 were $5.5 million compared with $1.9 million in the first nine months of 2003. The Company limited its capital expenditures in 2003 to maintenance level in order to conserve cash. The Company expects capital expenditures in 2004 to be in the range of $8.0 million to $10.0 million as the Company begins to reinvest in its remaining facilities, expand the Canton, Georgia facility to accommodate the transfer of Biomedical manufacturing to that facility and significantly expand the Company’s operations in China.

 

The Company received cash proceeds on the sale of assets of $1.8 million in the first nine months of 2004 compared with $16.1 million in the first nine months of 2003. The cash proceeds received in 2004 include $0.6 million from the sale of a vacant building and parcel of land at the New Prague, Minnesota facility, $1.1 million from the sale of equipment at the Plaistow, New Hampshire facility and $0.1 million from the sale of equipment at the Denver, Colorado facility. The cash proceeds received in 2003 include $13.6 million from the sale of certain assets and liabilities of the former Greenville Tube LLC stainless steel tubing business and $2.5 million from the sale of assets related to the closure of the Columbus, Ohio and Costa Mesa, California facilities. In October 2004, the Company received additional proceeds of $4.5 million in the fourth quarter of 2004 from the sale of its Burnsville, Minnesota facility.

 

22


Table of Contents

In the first nine months of 2004, the Company used $1.9 million of cash for its debt restructuring initiatives, compared with $12.6 million used in the first nine months of 2003. The payments made in the first nine months of 2004 include approximately $1.2 million in bankruptcy related fees to various professional service providers that the Company was required to delay until January 2004, when their fee applications were approved by the U.S. Bankruptcy Court. Other than these payments, the Company does not expect to use a significant amount of cash for debt restructuring initiatives in 2004.

 

Due to the significant amount of cash provided by operating activities in 2004, and management’s belief that cash forecasted to be generated by operations and the ability to borrow cash, if necessary, under the revolving credit portion of the Credit Facility, would be sufficient to satisfy its working capital, capital expenditure, restructuring and debt related cash requirements for 2004, on April 30, 2004 and September 27, 2004, the Company made voluntary prepayments of $10 million and $12 million, respectively, on the term loan portion of its Credit Facility. The prepayment reduced all future scheduled quarterly amortization payments on a pro-rata basis. These prepayments follow an additional voluntary $10.0 million prepayment made in December 2003.

 

Cash Requirements: The Company does not anticipate any unusual cash requirements for working capital needs in 2004. In order to complete its operational restructuring activities, particularly the closures of the Plaistow, New Hampshire and Burnsville, Minnesota facilities, the Company forecasts that it will use approximately $0.4 million of cash, in addition to the capital expenditure requirements discussed above, for one-time employee termination benefits, contract termination costs and other associated facility closure costs during the remaining three months of 2004. Based upon current actuarial estimates, the Company also expects to contribute approximately $0.2 million in cash to its four defined benefit pension plans to meet ERISA minimum funding requirements during the remaining three months of 2004.

 

As previously discussed, on March 28, 2003, CHEL filed for a voluntary administration under the U.K. Insolvency Act of 1986. CHEL’s application for voluntary administration was approved on April 1, 2003 and an administrator was appointed. Additionally, CHEL’s net pension plan obligations increased significantly, primarily due to a decline in plan asset values and interest rates, resulting in an estimated plan deficit of approximately $12.0 million. Based on the Company’s financial condition, in March 2003 it determined not to advance funds to CHEL in amounts necessary to fund CHEL’s obligations. CHEL did not have the necessary funds to enable it to fund its net pension plan deficit, pay remaining severance due to former employees or pay other creditors. As a result, the trustees of the CHEL pension plan requested a decision to wind-up the plan from a United Kingdom pension regulatory board, which approved the wind-up as of March 28, 2003.

 

At the present time, the Company is unable to determine the final financial impact of the April 1, 2003 approval of insolvency administration for CHEL and the related wind-up of CHEL’s United Kingdom pension plan. The Company can provide no assurance that claims will not be asserted against the Company for these obligations of CHEL. To the extent the Company has significant liability with respect to CHEL’s obligations as a result of CHEL’s insolvency, such liability could have a material adverse impact on the Company’s liquidity and its financial position.

 

Orders and Backlog

 

The following table sets forth orders by segment for the three-month periods ended September 30, 2004 and June 30, 2004 and backlog by segment as of September 30, 2004 and June 30, 2004:

 

     Three Months Ended,

     September 30, 2004

   June 30, 2004

Orders

             

Biomedical

   $ 19,443    $ 22,405

Distribution and Storage

     42,708      41,318

Energy and Chemicals

     17,379      24,559
    

  

Total

   $ 79,530    $ 88,282
    

  

Backlog

             

Biomedical

   $ 3,181    $ 3,577

Distribution and Storage

     39,198      38,916

Energy and Chemicals

     50,045      49,028
    

  

Total

   $ 92,424    $ 91,521
    

  

 

The Company considers orders to be those for which the Company has received a firm signed purchase order or other written contractual commitment from the customer. Backlog is comprised of the portion of firm signed purchase orders or other written contractual commitments received from customers that the Company has not recognized as revenue under the percentage of completion method or based upon shipment. The Company’s consolidated orders for the third quarter of 2004 totaled $79.5 million, compared with orders of $88.3 million for the second quarter of 2004. The Company’s

 

23


Table of Contents

consolidated firm order backlog at September 30, 2004 was $92.4 million, compared with $91.5 million at June 30, 2004. Backlog can be significantly affected by the timing of orders for large products, particularly in the Energy and Chemicals segment, and the amount of backlog at September 30, 2004 described above is not necessarily indicative of future backlog levels or the rate at which backlog will be recognized as sales.

 

Biomedical orders for the third quarter of 2004 totaled $19.4 million, compared with $22.4 million for the second quarter of 2004. Biomedical backlog totaled $3.2 million at September 30, 2004, compared with $3.6 million of backlog at June 30, 2004. Orders for medical and bio-medical products decreased $3.2 million due to lower demand, particularly the international customers, and orders for MRI components increased $0.2 million.

 

Distribution and Storage orders for the third quarter of 2004 totaled $42.7 million, compared with $41.3 million for the second quarter of 2004. Distribution and Storage backlog totaled $39.2 million at September 30, 2004, compared with $38.9 million of backlog at June 30, 2004. Orders for bulk storage systems and packaged gas systems increased $1.2 million and $0.2 million, respectively, from the second quarter.

 

Energy and Chemicals orders for the third quarter of 2004 totaled $17.4 million, compared with $24.6 million in the second quarter of 2004. Energy and Chemicals backlog totaled $50.0 million at September 30, 2004, compared with $49.0 million of backlog at June 30, 2004. Orders for heat exchangers decreased $1.1 million in the third quarter, however, orders are still strong in 2004 primarily due to improvements in the market and higher customer confidence resulting from the Company’s emergence from Chapter 11 reorganization. In October 2004, the Company received a significant heat exchangers order for $20.4 million. LNG systems experienced a decrease of $6.1 million in orders primarily resulting from lower demand for LNG Fueling and Storage Stations.

 

24


Table of Contents

Application of Critical Accounting Policies

 

The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles. As such, some accounting policies have a significant impact on amounts reported in these unaudited condensed consolidated financial statements. A summary of those significant accounting policies can be found in the Company’s 2003 Annual Report on Form 10-K, filed on March 30, 2004, in Note A of the Notes to the Consolidated Financial Statements and under the caption “Critical Accounting Policies” within Management’s Discussion and Analysis of Financial Condition and Results of Operations. In particular, judgment is used in areas such as revenue recognition for long-term contracts, determining the allowance for doubtful accounts and inventory valuation reserves, goodwill and indefinite lived intangibles, environmental remediation obligations, product warranty costs, debt covenants, pensions and deferred tax assets.

 

Forward-Looking Statements

 

The Company is making this statement in order to satisfy the “safe harbor” provisions contained in the Private Securities Litigation Reform Act of 1995. This Quarterly Report on Form 10-Q includes forward-looking statements relating to the business of the Company. In some cases, forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “continue” or the negative of such terms or comparable terminology. Forward-looking statements contained herein (including future cash contractual obligations) or in other statements made by the Company are made based on management’s expectations and beliefs concerning future events impacting the Company and are subject to uncertainties and factors relating to the Company’s operations and business environment, all of which are difficult to predict and many of which are beyond the control of the Company, that could cause actual results of the Company to differ materially from those matters expressed or implied by forward-looking statements. The Company believes that the following factors, among others (including those described in Item 7 of its Annual Report on Form 10-K for the year ended December 31, 2003 under “Certain Factors that May Affect Future Results and Financial Condition”), could affect its future performance and the liquidity of the Company’s equity securities and cause actual results of the Company to differ materially from those expressed or implied by forward-looking statements made by or on behalf of the Company: (a) general economic, political, business and market conditions and foreign currency fluctuations, (b) competition, (c) decreases in spending by the Company’s customers or the failure of the Company’s customers to make anticipated increases in spending, (d) the loss of a major customer or customers, (e) the effectiveness of operational changes expected to increase efficiency and productivity, (f) the ability of the Company to manage its fixed-price contract exposure, (g) the ability of the Company to pass on increases in raw material prices, (h) the Company’s relations with its employees, (i) litigation and disputes involving the Company, including the extent of product liability, pension and severance claims asserted against the Company, (j) variability in the Company’s operating results, (k) the ability of the Company to attract and retain key personnel, (l) the costs of compliance with environmental matters and responding to potential environmental liabilities, (m) the ability of the Company to protect its proprietary information, (n) the ability of the Company to sell certain assets on acceptable terms, (o) the ability of the Company to successfully realize operational restructuring savings and execute operational restructuring initiatives without unanticipated costs, (p) the ability of the Company to satisfy covenants under its Credit Facility and pay down its debt, (q) the insolvency of the Company’s Wolverhampton, United Kingdom manufacturing facility, operated by CHEL and the commencement of CHEL’s administration proceedings in the United Kingdom, including the potential liability of the Company with respect to CHEL’s obligations, and (r) the threat of terrorism and the impact of responses to that threat.

 

25


Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

In the normal course of business, the Company’s operations are exposed to continuing fluctuations in foreign currency values and interest rates that can affect the cost of operating and financing. Accordingly, the Company addresses a portion of these risks through a program of risk management.

 

The Company’s primary interest rate risk exposure results from the Credit Facility’s various floating rate pricing mechanisms. The Predecessor Company’s senior debt credit facility required the Company to enter into two interest rate derivative contracts (collars) in March 1999 to manage interest rate risk exposure. One of these collars continues to be outstanding after the bankruptcy and expires in March 2006. The fair value of the contract related to the interest rate collar outstanding at September 30, 2004 is a liability of $0.5 million. If interest rates were to increase 200 basis points (2 percent) from September 30, 2004 rates, and assuming no changes in debt from the September 30, 2004 levels, the additional annual expense would be approximately $1.7 million on a pre-tax basis.

 

The Company has assets, liabilities and cash flows in foreign currencies creating foreign exchange risk, the primary foreign currencies being the British Pound, the Czech Koruna and the Euro. Monthly measurement, evaluation and forward exchange contracts are employed as methods to reduce this risk. The Company enters into foreign exchange forward contracts to hedge anticipated and firmly committed foreign currency transactions. The Company does not hedge foreign currency translation or foreign currency net assets or liabilities. The terms of the derivatives are one year or less. If the value of the U.S. dollar were to strengthen 10 percent relative to the currencies in which the Company has foreign exchange forward contracts at September 30, 2004, the result would be a loss in fair value of approximately $0.3 million.

 

Item 4. Controls and Procedures

 

As of September 30, 2004 an evaluation was performed, under the supervision and with the participation of the Company’s management including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Based upon that evaluation, such officers concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms.

 

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

26


Table of Contents

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

In March 2003, the Company completed the closure of its Wolverhampton, United Kingdom manufacturing facility, operated by CHEL, and all current heat exchanger manufacturing is being conducted at the Company’s LaCrosse, Wisconsin facility. On March 28, 2003, CHEL filed for a voluntary administration under the U.K. Insolvency Act of 1986. CHEL’s application for voluntary administration was approved on April 1, 2003 and an administrator was appointed. Additionally, CHEL’s net pension plan obligations increased significantly, primarily due to a decline in plan asset values and interest rates, resulting in an estimated plan deficit of approximately $12 million. Based on the Company’s financial condition, in March 2003 the Company determined not to advance funds to CHEL in amounts necessary to fund CHEL’s obligations. CHEL did not have the necessary funds to enable it to fund its net pension plan deficit, pay remaining severance due to former employees or pay other creditors. As a result, the trustees of the CHEL pension plan requested a decision to wind-up the plan from a United Kingdom pension regulatory board, which approved the wind-up as of March 28, 2003. As of June 30, 2004, the Company is unable to determine the financial impact of the April 1, 2003 approval of insolvency administration for CHEL and the related wind-up of CHEL’s United Kingdom pension plan. The Company can provide no assurance that claims will not be asserted against the Company for these obligations of CHEL. To the extent the Company has significant liability with respect to CHEL’s obligations as a result of CHEL’s insolvency, such liability could have a material adverse impact on the Company’s liquidity and its financial position.

 

On July 8, 2003, the Company and all of its then majority-owned U.S. subsidiaries filed voluntary petitions for reorganization relief under Chapter 11 of the U.S. Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to implement an agreed upon senior debt restructuring plan through a pre-packaged plan of reorganization. None of the Company’s non-U.S. subsidiaries were included in the filing in the Bankruptcy Court. On September 15, 2003, the Company (as reorganized, the “Reorganized Company”) and all of its majority-owned U.S. subsidiaries emerged from Chapter 11 proceedings pursuant to the Amended Joint Prepackaged Reorganization Plan of Chart Industries, Inc. and Certain Subsidiaries, dated September 3, 2003 (the “Reorganization Plan”), which the Bankruptcy Court confirmed by an order entered on September 4, 2003. Under the Reorganization Plan, the Company’s senior debt of $255.7 million and related interest and fees of $1.9 million were converted into a $120.0 million secured term loan, with the balance of the existing senior debt being cancelled in return for an initial 95 percent equity ownership position in the Reorganized Company, and the Company’s $40.0 million secured debtor-in-possession financing facility was amended and restated as a $40.0 million post-bankruptcy secured revolving credit facility. In addition, on September 15, 2003, all of the Company’s common stock, warrants, options and other rights to acquire the Company’s common stock were cancelled, and the Company’s former stockholders received five percent of the initial equity of the Reorganized Company and the opportunity to acquire up to an additional five percent of equity through the exercise of new warrants. Further information concerning the Company’s Chapter 11 reorganization is set forth in the Reorganization Plan and the related Confirmation Order of the Bankruptcy Court, which were filed as exhibits to the Company’s Current Reports on Form 8-K and Form 8-K/A, each dated September 4, 2003. The Company continues to resolve a number of proofs of claim asserted in the bankruptcy proceedings, including a finder’s fee claim asserted in the amount of $2.3 million by a former significant stockholder of the Company, against which the Company intends to defend vigorously. The Company has moved for summary judgment with regard to the finder’s fee claim. The Bankruptcy Court has stayed discovery on the finder’s fee claim pending its consideration of the Company’s summary judgment motion.

 

The Company is a party to other legal proceedings incidental to the normal course of its business. Based on the Company’s historical experience in litigating these actions, as well as the Company’s current assessment of the underlying merits of the actions and applicable insurance, management believes that the final resolution of these matters will not have a material adverse affect on the Company’s financial position, liquidity, cash flows or results of operations.

 

27


Table of Contents

Item 2. Unregistered Sales of Equity Securities

 

During the quarterly period ended September 30, 2004, the Company issued an aggregate of 5,378 shares of New Common Stock upon the exercise of New Warrants. The New Warrants may be exercised by either paying a cash exercise price of $32.97 per share, which is subject to adjustments under the Warrant Agreement, dated September 15, 2003, between the Company and National City Bank, as warrant agent (the “Warrant Agreement”), or by utilizing the cashless exercise feature provided in the Warrant Agreement. The table below provides additional detail regarding issuance of New Common Stock upon the exercise of New Warrants during the quarterly period ended September 30, 2004:

 

Date of Exercise


 

New Warrants

Exercised


 

Methods of Exercise


 

Shares of New

Common Stock Issued


July 15

            2   Cash          2

August 12

  26,390   Cashless   5,323

September 29


 

        53


 

Cash


 

     53


Total

  26,445       5,378

 

The issuance of the 5,378 shares of New Common Stock upon the exercise of New Warrants was made in reliance on the exemption from the registration requirements of the Securities Act of 1933, as amended, provided by Section 1145(a) of the U.S. Bankruptcy Code, on the basis that the New Common Stock was offered and sold upon the exercise of warrants that were offered and sold under a plan of a debtor in exchange for an interest in the debtor.

 

Item 6. Exhibits and Reports on Form 8-K

 

  (a) Exhibits.

 

See the Exhibit Index on page 30 of this Form 10-Q.

 

28


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    Chart Industries, Inc.
    (Registrant)
Date: November 12, 2004  

/s/ Michael F. Biehl


    Michael F. Biehl
    Chief Financial Officer and Treasurer
   

(Duly Authorized Principal Financial Officer and

Chief Accounting Officer)

 

29


Table of Contents

EXHIBIT INDEX

 

Exhibit
Number


 

Description of Document


31.1   Rule 13a-14(a) Certification of Chief Executive Officer
31.2   Rule 13a-14(a) Certification of Chief Financial Officer
32.1   Section 1350 Certification of Chief Executive Officer
32.2   Section 1350 Certification of Chief Financial Officer

 

30